Relay Therapeutics, Inc. Profile Avatar - Palmy Investing

Relay Therapeutics, Inc.

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indi…

Biotechnology
US, Cambridge [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
Relay Therapeutics, Inc. can't present any analysts estimates at the moment detail analysis.
End of RLAY's Analysis
CIK: 1812364 CUSIP: 75943R102 ISIN: US75943R1023 LEI: - UEI: -
Secondary Listings
RLAY has no secondary listings inside our databases.